OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Bristol Myers Squibb
Nicola Hulme is a senior research scientist, Bristol Myers Squibb, UK, email@example.com
April 02, 2017
The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.